Ingalfarma announces that its product Dentoxol® has been incorporated into the GES programme of one of the most important health insurance companies in the country, in prophylaxis of oral mucositis in lung cancer.
Menu
Ingalfarma announces that its product Dentoxol® has been incorporated into the GES programme of one of the most important health insurance companies in the country, in prophylaxis of oral mucositis in lung cancer.